Papilledema: Difference between revisions

(→‎Clinical Features: reference for visual obscurations)
(→‎Differential Diagnosis: Expand differential, include CVT)
Line 26: Line 26:


==Differential Diagnosis==
==Differential Diagnosis==
*[[Malignant hypertension]]
*[[Idiopathic intracranial hypertension]] (other causes must be excluded)
*[[Idiopathic intracranial hypertension]] (pseudotumor cerebri)
*[[Intracranial mass]]
*[[Intracranial mass]]
*[[Hydrocephalus]]
*[[Hydrocephalus]]
*[[Cerebral venous thrombosis]]
*Cerebral edema
*Cerebral edema
*[[Salicylate toxicity]]
**[[Ischemic stroke]]
**[[Head trauma (main)|Traumatic brain injury]]
**[[Salicylate toxicity]]
**[[Meningitis]]
**[[Encephalitis]]
**[[Posterior reversible encephalopathy syndrome]]


==Evaluation==
==Evaluation==

Revision as of 20:03, 22 August 2025

Background

  • Bilateral optic disc swelling due to increased ICP
  • This may sometimes be a presenting complaint, referred by an eye care provider, though will usually have associated symptoms such as headache, altered mental status, or vision changes.

Etiology

Clinical Features

  • Increased ICP symptoms:
  • Visual disturbance
    • Visual acuity is usually normal or near-normal in the acute phase
    • May have transient visual obscurations (blurriness or white out) that last seconds, then clear completely.[1]
      • These may be triggered by position change or Valsalva

Fundoscopy

Papilledema.jpg
  • Loss of spontaneous venous pulsations
  • Disc margin blurring
  • Cup is diminished or absent

Differential Diagnosis

Evaluation

  • MRI
  • CT (if MRI unavailable)
  • LP (if neuroimaging normal)
    • Opening pressure >25 considered abnormal

Management

  • Treat underlying condition

See Also

External Links

References

  1. 1.0 1.1 Xie JS, et al. Papilledema: A review of etiology, pathophysiology, diagnosis, and management. Surv Ophthalmol. 2022;67(4):1135-1159.